Baclofen Treatment of Ataxia Telangiectasia

Status Completed

Clinical Trial Summary

This research is being done to find out if Baclofen, a medicine that is often used for the treatment of abnormal stiffness, might also be useful to treat some of the neurologic problems caused by ataxia telangiectasia (A-T). The investigators also want to find out if there are better ways to measure the problems of ataxia and abnormal eye movement for future studies of medication in ataxia telangiectasia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00640003
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Completed
Phase	Early Phase 1
Start date	April 2007
Completion date	February 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02345135` - Susceptibility to Infections in Ataxia Telangiectasia	N/A
Active, not recruiting	`NCT04991701` - A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia
Active, not recruiting	`NCT05531890` - Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects	Phase 1
Recruiting	`NCT05692596` - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Completed	`NCT05252819` - Whole Body MRI for Cancer Surveillance in A-T
Recruiting	`NCT03357978` - Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia	N/A
Withdrawn	`NCT02309632` - Pancreatic Cancer Screening of High-Risk Individuals in Arkansas	N/A
Not yet recruiting	`NCT06324877` - Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside	N/A
Not yet recruiting	`NCT01075438` - Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients	N/A
Completed	`NCT03962114` - Effects of Vitamin B3 in Patients With Ataxia Telangiectasia	Phase 2
Completed	`NCT04513002` - Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis	Phase 2
Completed	`NCT05471310` - Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia
Active, not recruiting	`NCT04870866` - NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia	Phase 2
Recruiting	`NCT06193200` - To Evaluate the Effects of EryDex in Patients With A-T	Phase 3
Recruiting	`NCT03563053` - Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study	Phase 3
Recruiting	`NCT05692622` - Home-based Complex Intervention for Children With Ataxia Telangiectasia	N/A
Recruiting	`NCT04037189` - Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Not yet recruiting	`NCT04887311` - MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia	Phase 2
Active, not recruiting	`NCT00951886` - The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally	N/A
Recruiting	`NCT03759678` - N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)	Phase 2